Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer

Combination comprising macitentan and paclitaxel for treating multi-drug resistant ovarian cancer

US Patent 8541433 · Granted Sep 24, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Pharmaceutical combination comprising a selective S1P1 receptor agonist2025
Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for t2023
Pharmaceutical combination comprising ponesimod2023
Pharmaceutical combination comprising a selective S1P1 receptor agonist2023
Combinations of a 4-pyrimidinesulfamide derivative with active ingredients for t2021
Pharmaceutical combination comprising a selective S1P1 receptor agonist2021
Pharmaceutical combination comprising a selective S1P1 receptor agonist2019
Therapeutic compositions containing macitentan2017
Therapeutic compositions containing macitentan2015
Therapeutic compositions containing macitentan2014
Therapeutic compositions comprising a specific endothelin receptor antagonist an2012
Sulfamides as endothelin receptor antagonists for the treatment of cardiovascula2011